Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amylyx Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

Public

Amylyx Pharmaceuticals: A global biopharmaceutical firm innovating therapies for ALS and neurodegenerative diseases.

HQ
Cambridge, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Amylyx Pharmaceuticals, founded with a mission to discover and develop treatments for neurodegenerative diseases, focuses primarily on amyotrophic lateral sclerosis (ALS) and other similar conditions. The company offers proprietary therapeutic solutions aimed at improving the quality of life for individuals affected by these relentless diseases. Amylyx serves a global market, dedicated to creating more meaningful moments for patients and their families.

Notable figures associated with Amylyx include its founders and key investors who have supported its innovative approach to biopharmaceutical development. The company has achieved significant milestones, including the development of promising therapies that have shown potential in clinical trials. Amylyx's impact is marked by its commitment to the neurodegenerative disease community, striving to bring hope and improved outcomes to those living with these challenging conditions.

Amylyx Pharmaceuticals - Similar Companies

Axsome Therapeutics logo

Axsome Therapeutics

axsome.com

Denali Therapeutics logo

Denali Therapeutics

Amicus Therapeutics logo

Amicus Therapeutics

amicusrx.com

Allyx Therapeutics logo

Allyx Therapeutics

allyxthera.com

Link Medicine logo

Link Medicine

linksciences.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Harmony Biosciences logo

Harmony Biosciences

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

QurAlis logo

QurAlis

Neuraly logo

Neuraly

neuralymed.com

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Mitochon Pharmaceuticals logo

Mitochon Pharmaceuticals

mitochonpharma.com

Aptinyx logo

Aptinyx

aptinyx.com

Amylyx Pharmaceuticals - Quick Facts

Who are Amylyx Pharmaceuticals' competitors?

Companies similar to Amylyx Pharmaceuticals include Axsome Therapeutics, Denali Therapeutics, Amicus Therapeutics and Allyx Therapeutics.

When was Amylyx Pharmaceuticals founded?

Amylyx Pharmaceuticals was founded in 2014.

Where is Amylyx Pharmaceuticals' headquarters located?

Amylyx Pharmaceuticals' headquarters is located in Cambridge, MA, US.

When was Amylyx Pharmaceuticals' last funding round?

Amylyx Pharmaceuticals' most recent funding round was for $246.3M (USD) in October 2022.

How much has Amylyx Pharmaceuticals raised to-date?

As of Oct 6, 2022, Amylyx Pharmaceuticals has raised a total of $448.5M (USD).

How many employees does Amylyx Pharmaceuticals have?

Amylyx Pharmaceuticals has 262 employees as of Feb 6, 2024.

Amylyx Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 464600503
  • secCik: 0001658551
  • ticker: AMLX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research